Medigus (NASDAQ: MDGS) reported Q2 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Medigus earnings for the quarter were N/A. In the same quarter last year, Medigus's earnings per share (EPS) was N/A.
As of Q4 2023, Medigus's earnings has grown year over year. Medigus's earnings in the past year totalled -$14.60 million.
What was MDGS's revenue last quarter?
Medigus (NASDAQ: MDGS) reported Q2 2023 revenue of N/A up N/A year over year. In the same quarter last year, Medigus's revenue was N/A.
What was MDGS's revenue growth in the past year?
As of Q4 2023, Medigus's revenue has grown 96.44% year over year. This is 90.51 percentage points higher than the US Medical Devices industry revenue growth rate of 5.93%. Medigus's revenue in the past year totalled $83.45 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.